Mereo BioPharma Group plc (MREO) Balance Sheet Annual - Discounting Cash Flows
MREO
Mereo BioPharma Group plc
MREO (NASDAQ)
Period Ending: 2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
Report Filing: 2025-03-26 2024-03-27 2023-03-28 2022-03-31 2021-03-31 2020-06-15 2019-04-29 2017-12-31 2016-12-31 2015-12-31
Total Current Assets 74.76 63.76 62.13 99.32 29.73 30.43 34.5 63.18 60.78 81.28
Cash and Short Term Investments 69.8 57.42 56.33 94.3 23.47 16.35 27.54 52.54 53.58 79.68
Cash & Equivalents 69.8 57.42 56.33 94.3 23.47 16.35 25.04 50.04 53.58 79.68
Short Term Investments 0 0 51.1 0.569 0.547 0.544 2.5 2.5 0 0
Receivables 3.25 3.73 2.75 1.42 1.02 0 0 0 0 0
Inventory 0 0 -2.67 -1.82 -4.64 -11.98 -0.293 -2.5 -53.92 0
Other Current Assets 1.71 2.61 5.72 5.43 9.88 26.07 7.25 13.13 61.12 1.6
Total Assets 76.39 66.5 88.08 126.4 62.95 86.45 67.28 96.34 86.76 107.3
Total Non-Current Assets 1.63 2.74 25.95 27.09 33.22 56.01 32.78 33.16 25.99 26.02
Property, Plant and Equipment 0.984 1.65 1.83 2.53 1.57 11.56 0.149 0.153 0.174 0.205
Goodwill and Intangible Assets 0.643 1.09 24.12 24.56 31.65 44.46 32.63 33.01 25.81 25.81
Goodwill 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0.643 1.09 24.12 24.56 31.65 44.46 32.63 33.01 25.81 25.81
Long Term Investments 0 0 0 0 0 0 0 0 0 0
Deferred Tax Assets 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0 0 0 0 0 0 0 0 0 0
Total Current Liabilities 13.85 9.49 24.68 12.54 8.56 29.88 16.18 9.62 3.21 2.82
Accounts Payable 2.44 2.35 3.49 2.29 2.94 5.88 5.57 2.64 1.23 1.08
Notes Payable/Short Term Debt 6.24 0.652 11.59 0.622 0.636 17.73 6.84 1.94 0 0
Tax Payables 0.77 0.662 0.167 1.71 0.146 0.183 0.161 0.144 0.113 0
Deferred Revenue 0 0 0 8.37 0 5.45 -0.178 -0.164 0 0
Other Current Liabilities 4.4 5.83 9.43 -0.443 4.85 0.642 3.78 5.06 1.87 1.74
Total Liabilities 15.42 15.96 26.21 38.41 77.92 46.19 34.51 33.85 7.51 5.76
Total Non-Current Liabilities 1.57 6.48 1.53 25.87 69.35 16.32 18.33 24.23 4.3 2.94
Total Long Term Debt 0 5.3 1.48 1.75 17.3 19.26 14.65 18.81 3.13 2.8
Deferred Tax Liabilities Non-Current 0 0 0 0 0 0 0 0 0 0
Deferred Revenue Non-Current 0 0 0 0 0 0 0 0 0 0
Capital Lease Obligations 0.707 1.56 2.04 2.38 1.79 14.8 0 0 0 0
Other Long Term Liabilities 0.866 -0.382 -1.99 21.74 50.26 -17.75 3.68 5.42 1.17 0.141
Total Equity 60.97 50.54 61.87 88 -14.97 40.26 32.77 62.48 79.26 101.5
Non-Controlling Interest 0 0 0 0 0 0 0 0 0 0
Total Stockholders' Equity 60.97 50.54 61.87 88 -14.97 40.26 32.77 62.48 79.26 101.5
Retained Earnings -462.9 -419.6 -331.2 -297 -309.7 -146.1 -111.2 -79.32 -33.58 -12.19
Accumulated Other Earnings -18.85 -17.48 137.9 136.9 133.2 47.32 25.59 23.36 12.67 0
Common Stock 3.06 2.77 1.88 1.75 1.02 0.294 0.214 0.213 0.193 0.059
Preferred Stock 0 0 0 0 0 0 0 0 0 0
Additional Paid in Capital 539.6 484.9 488.1 383.2 294.7 198.6 173.6 168.1 125.5 15.75
Total Liabilities & Total Equity 76.39 66.5 88.08 126.4 62.95 86.45 67.28 96.34 86.76 107.3
Total Liabilities & Shareholders' Equity 76.39 66.5 88.08 126.4 62.95 86.45 67.28 96.34 86.76 107.3
Total Investments 0 0 51.1 0.569 0.547 0.544 2.5 2.5 0 0
Total Debt 6.43 5.95 12.77 16.76 17.94 32.42 21.48 20.75 3.13 2.8
Net Debt -63.37 -51.47 -43.56 -77.54 -5.53 16.07 -3.56 -29.29 -50.45 -76.88
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us